Today, Takeda has announced a significant step forward in its oncology portfolio with the signing of an option agreement with Ascentage Pharma. This agreement paves the way for Takeda to potentially enter into an exclusive global license for olverembatinib, a…
eClinical Solutions, a global leader in digital clinical software and services, has announced its participation in several upcoming industry events aimed at advancing biopharma efficiency through its elluminate® platform and biometrics services. These engagements come at a pivotal moment as…
CMI Media Group, a global healthcare media strategy agency and part of WPP (NYSE: WPP), has announced a pioneering partnership with KERV Interactive, a leader in AI-powered video analysis, performance, and monetization. This collaboration introduces innovative ‘Video Attention’ metrics tailored…
AstraZeneca’s supplemental New Drug Application (sNDA) for Tagrisso has been accepted and granted Priority Review in the US for treating adult patients with unresectable, Stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after chemoradiotherapy (CRT). If…
Genentech, a member of the Roche Group, shared today groundbreaking 5-year findings reaffirming the lasting effectiveness and safety of Evrysdi® (risdiplam) in children diagnosed with Type 1 spinal muscular atrophy (SMA). These insights stem from the open-label extension of the…
Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT), a global leader in messenger RNA medicines, focused on addressing unmet medical needs in infectious diseases and rare liver and respiratory conditions, unveiled Phase 1 findings in healthy volunteers and interim Phase 1b data…
The “Contact Layer Dressings Market – A Global and Regional Analysis: Focus on Region, Country-Level Analysis, and Competitive Landscape – Analysis and Forecast, 2023-2030” report has been added to ResearchAndMarkets.com’s offering. The global contact layer dressings market, valued at $538.3 million in 2022, is…
Helix, a prominent population genomics company, has introduced new clinico-genomic datasets aimed at empowering life science firms in advancing precision medicine drug discovery and development. These datasets, cultivated through Helix’s extensive collaborations with health systems, encompass comprehensive longitudinal clinical and…
Deborah Borst, a 74-year-old resident of Michigan, never fretted over her health, enjoying a life marked by robust well-being. Her hospital visits were limited to the joyous occasions of childbirth. However, in February 2021, her health narrative took an unexpected…
Incyte has finalized its acquisition of Escient Pharmaceuticals, a company specializing in the development of small molecule therapeutics for immune and neuro-immune disorders. The acquisition enhances Incyte’s Inflammation and Autoimmunity portfolio, reinforcing its dedication to addressing the pressing needs of…
WuXi Biologics, a prominent global Contract Research, Development, and Manufacturing Organization (CRDMO), has released its 2023 Environmental, Social, and Governance (ESG) Report, showcasing significant advancements in sustainable development. Aligned with its vision and mission, WuXi Biologics’ ESG strategy is deeply…
Shionogi & Co., Ltd. recently announced that its subsidiary, Qpex Biopharma, Inc., has exercised a $10 million option granted by the Biomedical Advanced Research and Development Authority (BARDA). This additional funding, part of an ongoing partnership with BARDA, aims to…
